Image

Tulip Airway in Difficult Mask Ventilation (TADMV)

Tulip Airway in Difficult Mask Ventilation (TADMV)

Recruiting
18-75 years
All
Phase N/A

Powered by AI

Overview

During surgery, right after anesthesia is given, the first step to help the patient breathe is to provide breathing support with a mask. This step is very important because if there is a problem with mask ventilation, the anesthesia team must quickly use other methods to help the patient breathe.

For some people, mask ventilation can be more difficult. Factors such as older age, having a beard, missing teeth, being overweight, sleep apnea, or certain facial shapes can make this process harder.

To make mask ventilation easier, special devices placed in the mouth are used. The most common one is called the Guedel airway. In recent years, a new device called the Tulip airway has also been introduced. The shape and features of the Tulip airway are designed to make breathing support easier.

In this study, we will compare the Tulip airway and the Guedel airway in patients who are expected to have more difficult mask ventilation. Our goal is to find out which device makes it easier and safer to help patients breathe.

Description

The first step in airway management following anesthesia induction is the period of bag-mask ventilation. This step is the most critical phase of airway management because, if mask ventilation fails, the anesthesiologist must make a life-saving decision for the patient. Bag-mask ventilation is a technical skill acquired over time; therefore, difficulty in mask ventilation may be related to either the provider or the patient. According to the literature, the incidence of difficult mask ventilation varies between 0.08% and 15% in different studies.

The American Society of Anesthesiologists (ASA) defines difficult mask ventilation as inadequate mask or supraglottic airway (SGA) ventilation, excessive air leakage, or excessive resistance to airflow during inspiration or expiration. Signs of inadequate ventilation include, but are not limited to, absent or insufficient chest movement, absent or diminished breath sounds, auscultatory signs of severe obstruction, cyanosis, gastric insufflation or distension, decreased or inadequate oxygen saturation (SpO₂), absence or inadequacy of end-tidal carbon dioxide (EtCO₂), absence or inadequacy of expiratory gas flow on spirometry, and hemodynamic changes associated with hypoxemia or hypercarbia (e.g., hypertension, tachycardia, arrhythmia).

Predictors of difficult mask ventilation include age over 55 years, the presence of a beard, poor mask fit due to secretions, edentulism, a history of snoring or obstructive sleep apnea syndrome (OSAS), and obesity. In anesthesia practice, when faced with difficult mask ventilation, various maneuvers, two-hand techniques, and adjunct airway devices are employed. Among these devices are various oral airways, the most common of which is the Guedel airway.

In recent years, new oral airway devices have been introduced as alternatives to the Guedel airway. The Tulip airway is a novel oral airway that is longer than the Guedel airway, equipped with a cuff, and features a connector that allows attachment to the breathing circuit. These characteristics enable it to be secured within the oral cavity via its cuff, and connection to the breathing circuit allows for airway management that may be more comfortable for the anesthesiologist compared to two-handed mask control.

The superiority of the Tulip airway over the Guedel airway has been demonstrated in patients with cervical spine injury, in edentulous manikins, and in patients undergoing general anesthesia. However, it has not been studied in patients with anticipated difficult mask ventilation. The aim of our study is to investigate whether the Tulip airway provides superior performance to the classical Guedel airway during the mask ventilation phase in patients with anticipated difficult mask ventilation. We hypothesize that the use of the Tulip airway in such patients will improve respiratory parameters and reduce the risk of complications during mask ventilation.

Eligibility

Inclusion Criteria:

  • Patients aged between 18 and 75 years
  • Patients scheduled for elective surgery under general anesthesia
  • Patients with at least two risk factors for difficult mask ventilation, including:
  • Age over 55 years
  • Presence of beard
  • Edentulism (missing teeth)
  • Obesity (Body Mass Index (BMI) ≥ 30 kg/m²)
  • History of obstructive sleep apnea syndrome (OSAS) or snoring
  • Neck circumference \> 43 cm
  • Retrognathia (small jaw structure)
  • Patients classified as American Society of Anesthesiologist (ASA) physical status 1, 2, or 3
  • Patients who provide informed consent

Exclusion Criteria:

  • Pregnant or breastfeeding women
  • Patients with a history of airway surgery (e.g., tracheostomy, maxillofacial surgery)
  • Patients with severe cardiopulmonary diseases (e.g., advanced Chronic obstructive Pulmonary Disease (COPD), pulmonary hypertension, severe heart failure)
  • Patients with craniofacial anomalies or significant anatomical airway deformities
  • Patients requiring emergency surgery
  • Patients with gastroesophageal reflux disease (GERD) and high risk of aspiration
  • Patients with active upper respiratory tract infection
  • Patients with a history of difficult intubation

Study details
    Difficult Mask Ventilation
    Airway Devices

NCT07204223

Ayse Zeynep Turan Civraz

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.